2.20

0.46% 0.01

Harvard Bioscience Inc (HBIO)

Overview News Price History Option Chain Financials Discussions Forecast

Harvard Bioscience Inc stock is traded at $2.20, with a volume of 108.05K. It is up +0.46% in the last 24 hours and down -5.17% over the past month. Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.

Previous Close:

$2.19

Open:

$2.23

24h Volume:

108.05K

Relative Volume:

0.80

Market Cap:

$97.28M

Revenue:

$106.79M

Net Income/Loss:

$-8.73M

P/E Ratio:

-16.92

EPS:

-0.13

Net Cash Flow:

$10.81M

1W Performance:

+1.85%

1M Performance:

-5.17%

6M Performance:

-30.38%

1Y Performance:

-50.45%

1-Day Range:

$2.185

$2.29

1-Week Range:

$2.09

$2.40

52-Week Range:

$1.99

$5.56

Harvard Bioscience Inc Stock (HBIO) Company Profile

Name

Harvard Bioscience Inc

Sector

Healthcare (1200)

Industry

Medical Instruments & Supplies (58)

Phone

(508) 893-8999

Address

84 OCTOBER HILL RD, HOLLISTON, MA

Employee

416

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

HBIO's Discussions on Twitter

Compare HBIO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HBIO Harvard Bioscience Inc	2.20	97.28M	106.79M	-8.73M	10.81M	-0.13
ISRG Intuitive Surgical Inc	538.55	192.83B	7.87B	2.24B	586.00M	4.25
BDX Becton Dickinson Co	221.98	64.77B	20.18B	1.73B	3.07B	5.51
ALC Alcon Inc	88.23	43.75B	9.76B	1.16B	665.00M	0.72
RMD Resmed Inc	249.33	36.84B	4.81B	1.11B	1.35B	6.16
WST West Pharmaceutical Services Inc	323.32	23.33B	2.88B	499.60M	321.60M	7.41

Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-10-23	Upgrade	The Benchmark Company	Speculative Buy → Buy
Jan-07-21	Upgrade	The Benchmark Company	Speculative Buy → Buy
Dec-09-20	Initiated	Northland Capital	Outperform
Nov-10-20	Initiated	KeyBanc Capital Markets	Overweight
Jul-08-19	Downgrade	Janney	Buy → Neutral
Jan-24-18	Reiterated	Janney	Buy
Jan-23-18	Reiterated	The Benchmark Company	Buy
Nov-17-16	Initiated	Singular Research	Buy
Jul-28-15	Initiated	The Benchmark Company	Buy

View All

Harvard Bioscience Inc Stock (HBIO) Latest News

Nov 22, 2024

Harvard Bioscience (HBIO) Stock Surges Amid Positive Analyst Rat - GuruFocus.com

Nov 22, 2024

Nov 21, 2024

HBIO stock touches 52-week low at $1.99 amid market challenges - Investing.com Australia

Nov 21, 2024

Nov 20, 2024

HBIO stock touches 52-week low at $1.99 amid market challenges By Investing.com - Investing.com South Africa

Nov 20, 2024

Nov 18, 2024

Harvard Bioscience, Inc. (NASDAQ:HBIO) Short Interest Up 13.8% in October - MarketBeat

Nov 18, 2024

HBIO stock touches 52-week low at $2.29 amid market challenges - Investing.com India

Nov 12, 2024

Harvard Bioscience (HBIO) Stock Dips Amid Market Volatility - GuruFocus.com

Nov 12, 2024

Nov 11, 2024

Harvard Bioscience, Inc. (NASDAQ:HBIO) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 11, 2024

Nov 09, 2024

Harvard Bioscience Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance

Nov 09, 2024

Nov 08, 2024

Harvard Bioscience (HBIO) Stock Surges with Positive Analyst Rat - GuruFocus.com

Nov 08, 2024